The family-owned Miele and Steelco Groups have agreed to join forces by combining their skills in medical technology.
One result is that Miele is to acquire a controlling stake in the Steelco Group, whilst Steelco founders remain at the helm of the group. Thanks to this combination, the medical technology division within the Miele Group is set to grow by around one third to approximately €250 m per annum.
The overarching aim is to provide clients with an even broader and more sophisticated range of products – as well as the best possible service, both before and after the sale. This transaction is still subject to approval of the anti-trust authorities.